[HTML][HTML] Copeptin, procalcitonin and routine inflammatory markers–predictors of infection after stroke

F Fluri, NG Morgenthaler, B Mueller, M Christ-Crain… - PloS one, 2012 - journals.plos.org
Background Early predictors for the development of stroke-associated infection may identify
patients at high risk and reduce post-stroke infection and mortality. Methods In 383 …

Detrimental consequences of brain injury on peripheral cells

A Catania, C Lonati, A Sordi, S Gatti - Brain, behavior, and immunity, 2009 - Elsevier
Acute brain injury and brain death exert detrimental effects on peripheral host cells. Brain-
induced impairment of immune function makes patients more vulnerable to infections that …

[HTML][HTML] Vascular protection following cerebral ischemia and reperfusion

SM Palomares, MJ Cipolla - Journal of neurology & …, 2011 - ncbi.nlm.nih.gov
Despite considerable research that has contributed to a better understanding of the
pathophysiology of stroke, translation of this knowledge into effective therapies has largely …

Neuroprotective effects of (−)-epigallocatechin-3-gallate against focal cerebral ischemia/reperfusion injury in rats through attenuation of inflammation

FJ Zhang, N Li, LL Jiang, LH Chen, MT Huang - Neurochemical research, 2015 - Springer
Stroke is the second leading cause of death among adults worldwide.(−)-Epigallocatechin-3-
gallate (EGCG) has been demonstrated to exhibit neuroprotective functions in cerebral …

Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysis

AM Gori, B Giusti, B Piccardi… - Journal of Cerebral …, 2017 - journals.sagepub.com
Inflammatory mediators and metalloproteinases are altered in acute ischemic stroke (AIS)
and play a detrimental effect on clinical severity and hemorrhagic transformation of the …

[HTML][HTML] Efficacy and safety of puerarin injection in curing acute ischemic stroke: A meta-analysis of randomized controlled trials

QH Zheng, XL Li, ZG Mei, L Xiong, QX Mei, JF Wang… - Medicine, 2017 - journals.lww.com
Background: Previous studies indicated that the puerarin injection has been widely
employed in China for the treatment of acute ischemic stroke. We aim to evaluate the …

Permeating the blood brain barrier and abrogating the inflammation in stroke: implications for stroke therapy

CV Borlongan, LE Glover… - Current …, 2012 - ingentaconnect.com
Cell therapy has been shown as a potential treatment for stroke and other neurological
disorders. Human umbilical cord blood (HUCB) may be a promising source of stem cells for …

The predicting role of neutrophil–lymphocyte ratio in patients with acute ischemic and hemorrhagic stroke

M Dehghanei, R ArefNezhad, H Motedayyen - Journal of Stroke and …, 2020 - Elsevier
Background and aim The neutrophil-to-lymphocyte ratio (NLR) is considered as an
independent and easy-to-measure inflammatory predictor of mortality in patients with acute …

Is plasma fibrinogen useful in evaluating ischemic stroke patients? Why, how, and when

M Di Napoli, P Singh - Stroke, 2009 - Am Heart Assoc
In this issue of Stroke, del Zoppo et al1 report new data on the association between
hyperfibrinogenemia and functional prognosis after ischemic stroke using the placebo data …

Neuroprotective effects of DTIO, a novel analog of Nec-1, in acute and chronic stages after ischemic stroke

W Li, J Liu, JR Chen, YM Zhu, X Gao, Y Ni, B Lin, H Li… - Neuroscience, 2018 - Elsevier
Receptor-interacting protein 1 kinase (RIP1K) plays a key role in necroptosis. Necrostatin-1
(Nec-1), a specific inhibitor of RIP1K, provides neuroprotection against ischemic brain injury …